BLOG / 🇺🇸 United States · · daily

VA Healthcare & Services Contracts — August 09, 2026

VA Healthcare & Services Contracts

By Gunpowder Editorial ·

1 total filings analysed

Executive Summary

This digest covers a single, large civilian contract from the Department of Veterans Affairs (VA) valued at $209.2 million, awarded to QTC Medical Services Inc., a subsidiary of Leidos Holdings, Inc. The contract, for medical disability examinations in the Southeast region, is a firm-fixed-price delivery order with a one-year performance period that has been nearly fully executed ($196.6M outlayed).

While the award demonstrates Leidos' established position in the VA medical evaluation market, the neutral signal and lack of forward-looking growth visibility due to the short-term, completed nature of the contract limit bullish conviction. Key risks include the absence of a clear follow-on award and the fixed-price structure, which caps upside. The primary watch item is Leidos' ability to secure subsequent VA contracts in this or other regions to sustain this revenue stream.

Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →

Tracking the trend? Catch up on the prior VA Healthcare & Services Contracts digest from August 02, 2026.

Investment Signals (1)

  • Leidos Subsidiary QTC Medical Services Completes $209.2M VA Contract for Disability Exams (MEDIUM)

    QTC Medical Services, a Leidos subsidiary, secured a $209.2 million firm-fixed-price delivery order from the VA for medical disability examinations, with $196.6 million already outlayed. The contract's completion and fixed-price nature provide a confirmed but non-recurring revenue stream, offering limited visibility into future growth.

Risk Flags (2)

  • Concentration [HIGH RISK]

    Leidos' reliance on a single, completed VA contract for $209.2 million in the Southeast region creates a concentration risk if follow-on awards are not secured. The one-year performance period and near-full outlay ($196.6M) mean this revenue stream has largely ended, with no new contract data indicating renewal.

  • Execution [MEDIUM RISK]

    The firm-fixed-price structure of the $209.2 million contract transfers cost overrun risk to Leidos. If examination volumes or complexity exceeded estimates, margins could have been compressed, though the near-complete outlay suggests manageable execution.

Opportunities (1)

  • Leidos, via QTC Medical Services, has a proven track record with the VA for medical disability examinations, positioning it favorably for future VA contracts in other regions or for expanded services. The VA's sustained demand for such evaluations provides a stable pipeline.

Sector Themes (1)

  • The $209.2 million contract underscores the VA's consistent funding for medical disability examinations, a non-discretionary service tied to veteran benefits. This creates a stable, albeit competitive, market for contractors like Leidos.

Watch List (2)

  • 👁

    {"entity" => "Leidos Holdings, Inc.", "reason" => "The $209.2 million VA contract is a significant but completed revenue stream; future growth depends on securing follow-on awards.", "trigger" => "VA re-compete announcement for Region 2 medical disability exams or new task orders in other regions"}

  • 👁

    {"entity" => "Department of Veterans Affairs", "reason" => "As the sole buyer, any shift in VA procurement policies, budget cuts, or increased competition could impact Leidos' market share.", "trigger" => "VA budget proposal for FY2022, NDAA provisions affecting veteran medical services"}

Get daily alerts with 1 investment signals, 2 risk alerts, 1 opportunities and full AI analysis of all 1 filings

$30/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.

More from: VA Healthcare & Services Contracts

🇺🇸 More from United States

View all →